J Korean Soc Neonatol. Search


Journal of the Korean Society of Neonatology 2007;14(2):153-161.
Published online November 1, 2007.
The Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Alveolarization Inhibition Induced by Hyperoxia in Neonatal Rat.
Chang Won Choi, Beyong Il Kim, In Suk Lim, Hyun Joo Lee, Kyoung Eun Joung, Gyu Hong Shim, Jin A Lee, Ee Kyung Kim, Han Suk Kim, Jung Hwan Choi
1Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. beyil@snu.ac.kr
2Department of Pediatrics, Bundang Cha Hospital, Pochon Cha University College of Medicine, Gyeonggi-do, Korea.
과산소에 의한 폐포화 저해 신생쥐 모델에서의 골수유래 중간엽 줄기세포의 치료효과
, , , , , , , , ,
We sought to determine whether bone marrow-derived mesenchymal stem cells (BMMSC) could attenuate the inhibition of alveolarization induced by hyperoxia.
Human BMMSC (SNU-hMSC) were infused into the peritoneal cavity (IP) or trachea (IT) of neonatal rats exposed to hyperoxia (90% O2 from D1) on D5. The rats were then exposed to the same degree of hyperoxia for another 9d and sacrificed on D21. Morphometric analysis of the lungs and immunofluorescent staining in order to determine cell fates of infused SNU-hMSC were performed.
The airspace of the hyperoxia control group (90% O2 for 14d) was significantly larger and more simple (mean linear intercept [Lm] : 68+/-16 micrometer vs 33+/-3 micrometer) and the alveolar surface area [SA] was significantly smaller (646+/-72 cm2 vs 1,042+/-477 cm2) than those of the normoxia control group. The Lm of the BMMSC- infused groups was significantly shorter irrespective of infusion route (52+/-2 micrometer [IP], 50+/-8 micrometer [IT] vs 68+/-16 micrometer) and the SA of the BMMSC IP infusion group was significantly larger (646+/-172 cm2 vs 346+/-142 cm2) than those of the hyperoxia control group. The IT-, but not IP-, infused BMMSC groups were observed in lung tissue and assumed to be type I and type II alveolar epithelial cell phenotypes.
BMMSC, when infused into neonatal rats exposed to hyperoxia, significantly attenuated the inhibition of alveolarization irrespective of the infusion route. It seems that BMMSC, when infused IT, engrafts into lung tissue and differentiates into alveolar epithelial cells. These results indicate that BMMSC could be considered as a potential candidate therapy for bronchopulmonary dysplasia.
Key Words: Mesenchymal stem cells; Alveolarization; Bronchopulmonary dysplasia
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 2,307 View
  • 7 Download


Browse all articles >

Editorial Office
34, Sajik-ro 8–gil(King’s Gargen 3 Block 1207), Jongno-gu, Seoul 03174, Republic of Korea
Tel: +82-2-730-1993    Fax: +82-2-730-1994    E-mail: neonate2002@naver.com                

Copyright © 2024 by The Korean Society of Neonatology.

Developed in M2PI

Close layer
prev next